Avoro Capital Advisors LLC Xenon Pharmaceuticals Inc. Call Options Transaction History
Avoro Capital Advisors LLC
- $6.65 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XENE
# of Institutions
212Shares Held
70.2MCall Options Held
88.3KPut Options Held
28.8K-
Driehaus Capital Management LLC Chicago, IL4.6MShares$177 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$148 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.71MShares$104 Million3.02% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$104 Million9.03% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$103 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.4B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...